Triple Negative Breast Cancer
Showing 26 - 50 of 307
Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Triple Negative Breast Cancer
- +6 more
- Implantable Microdevice (IMD)
-
Boston, Massachusetts
- +1 more
Mar 8, 2023
Looking At Triple Negative Breast Cancer Patient Experience
Not yet recruiting
- Triple Negative Breast Cancer
- Breast Cancer
- (no location specified)
Mar 3, 2023
Breast Cancer, Triple Negative Breast Cancer, Dietary Exposure Trial (Control diet (ARM A) or Fasting-Like Approach (FLA, ARM
Not yet recruiting
- Breast Cancer
- +3 more
- Control diet (ARM A) or Fasting-Like Approach (FLA, ARM B)
- (no location specified)
Feb 28, 2023
Ovarian Cancer, Melanoma, Triple Negative Breast Cancer Trial (NM1F Injection, Pembrolizumab injection)
Not yet recruiting
- Ovarian Cancer
- +3 more
- NM1F Injection
- Pembrolizumab injection
- (no location specified)
Feb 23, 2023
Patient Decision Making in Early Stage Breast Cancer:Conjoint
Recruiting
- Triple Negative Breast Cancer
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Feb 14, 2023
Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)
Not yet recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Imatinib 400 MG Oral Tablet
-
Gothenburg, SwedenBarbro Linderholm
Feb 1, 2023
Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,
Not yet recruiting
- Advanced Cancer
- +16 more
- Fosifloxuridine Nafalbenamide
- +3 more
-
Birmingham, United Kingdom
- +3 more
Feb 1, 2023
Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)
Recruiting
- Triple Negative Breast Cancer
- +14 more
- LYL797
-
Scottsdale, Arizona
- +10 more
Jan 30, 2023
Triple Negative Breast Cancer, Breast Cancer Trial in United States (Carboplatin, Docetaxel, Doxorubicin)
Recruiting
- Triple Negative Breast Cancer
- Breast Cancer
- Carboplatin
- +4 more
-
Fairway, Kansas
- +5 more
Jan 26, 2023
Triple Negative Breast Cancer Trial in United States (Sacituzumab govitecan-hziy (SG), Pembrolizumab, Capecitabine)
Recruiting
- Triple Negative Breast Cancer
- Sacituzumab govitecan-hziy (SG)
- +2 more
-
Glendale, Arizona
- +7 more
Jan 26, 2023
Triple Negative Breast Cancer, Breast Cancer Trial in United States (Trilaciclib, Cylophosphamide, Doxorubicin)
Active, not recruiting
- Triple Negative Breast Cancer
- Breast Cancer
- Trilaciclib
- +5 more
-
Los Alamitos, California
- +6 more
Jan 25, 2023
Triple Negative Breast Cancer, Metastatic Breast Cancer Trial (Sacituzumab govitecan)
Not yet recruiting
- Triple Negative Breast Cancer
- Metastatic Breast Cancer
- Sacituzumab govitecan
- (no location specified)
Jan 23, 2023
Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (proton plus carbon ion radiotherapy)
Recruiting
- Triple Negative Breast Cancer
- HER2-positive Breast Cancer
- proton plus carbon ion radiotherapy
-
Shanghai, ChinaShanghai Proton and Heavy Ion center
Jan 11, 2023
Triple Negative Breast Cancer, PD-L1 Negative Trial in Puerto Rico, United States (Sacituzumab Govitecan-hziy, Paclitaxel,
Recruiting
- Triple Negative Breast Cancer
- PD-L1 Negative
- Sacituzumab Govitecan-hziy
- +4 more
-
Anchorage, Alaska
- +231 more
Jan 17, 2023
Breast Cancer, Triple Negative Breast Cancer Trial in United States (Capecitabine, Talazoparib, Atezolizumab)
Recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Capecitabine
- +4 more
-
Washington, District of Columbia
- +5 more
Jan 12, 2023
Triple Negative Breast Cancer, PD-L1 Positive Trial in Puerto Rico, United States (Sacituzumab Govitecan-hziy, Pembrolizumab,
Recruiting
- Triple Negative Breast Cancer
- PD-L1 Positive
- Sacituzumab Govitecan-hziy
- +5 more
-
Anchorage, Alaska
- +245 more
Jan 12, 2023
Triple Negative Breast Cancer, HER2-negative Breast Cancer Trial in Tampa (HER2 - primed Dendritic cells, HER3 - primed
Recruiting
- Triple Negative Breast Cancer
- HER2-negative Breast Cancer
- HER2 - primed Dendritic cells
- HER3 - primed Dendritic cells
-
Tampa, FloridaMoffitt Cancer Center
Jan 10, 2023
Breast Cancer Female, Triple Negative Breast Cancer Trial (quercetin, EGCG, metformin , zinc)
Not yet recruiting
- Breast Cancer Female
- Triple Negative Breast Cancer
- quercetin, EGCG, metformin , zinc
- (no location specified)
Dec 23, 2022
Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)
Recruiting
- Triple Negative Breast Cancer
- +5 more
-
Manchester, Greater Manchester, United Kingdom
- +6 more
Jan 5, 2023
NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)
Recruiting
- Non-small Cell Lung Cancer
- +11 more
-
Birmingham, Alabama
- +32 more
Jan 4, 2023
Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple
Recruiting
- Triple Negative Breast Cancer
-
New Haven, Connecticut
- +2 more
Jan 4, 2023